MODELLING AND BIOPHARMACEUTICAL EVALUATION OF CICLOPIROX OLAMINE GELS

被引:0
|
作者
Mazurkevicute, Agne [1 ]
Ramanauskiene, Kristina [1 ]
Ivaskiene, Marija [2 ]
Grigonis, Aidas [2 ]
Briedis, Vitalis [1 ]
机构
[1] Lithuanian Univ Hlth Sci, Fac Pharm, Dept Clin Pharm, Sukileliai Ave 13, LT-50161 Kaunas, Lithuania
[2] Lithuanian Univ Hlth Sci, Fac Vet Med, Vet Acad, Dept Noninfect Dis, Tilte St 18, LT-47181 Kaunas, Lithuania
来源
ACTA POLONIAE PHARMACEUTICA | 2017年 / 74卷 / 02期
关键词
ciclopirox olamine; gel; rheology; chitosan; hydroxypropyl cellulose; poloxamer; 407; IN-VITRO SUSCEPTIBILITY; RHEOLOGICAL CHARACTERIZATION; HYDROXYPROPYL CELLULOSE; ANTIFUNGAL AGENTS; POLYMERS; PERMEATION; BEHAVIOR; RELEASE; SYSTEMS; SKIN;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ciclopirox olamine (CPO) has a broad antimicrobial profile including dermatophytes, yeasts and is used in various pharmaceutical forms. The aim of this study is to evaluate the quality of the CPO gels according to biopharmaceutial tests in vino and antifungal activity assay. Hydroxypropyl cellulose, chitosan and poloxamer 407 were selected as agents gelificants. The effects of gelling agent properties and concentration on the consistency and flow characteristics have been studied by rheometer. CPO release rates from gel were measured with Franz type diffusion cells. The antifungal activity of gels was tested using agar well diffusion technique. The results of the experimental study have shown that the rheological properties of the medications depend on the selected gelling agent and the amount of it. The higher amounts of CPO were released from the poloxamer 407 gels. Though all tested CPO gels showed great inhibition of Microsponm canis.
引用
收藏
页码:543 / 549
页数:7
相关论文
共 50 条
  • [31] Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK
    Zhou, Hongyu
    Shang, Chaowei
    Wang, Min
    Shen, Tao
    Kong, Lingmei
    Yu, Chunlei
    Ye, Zhennan
    Luo, Yan
    Liu, Lei
    Li, Yan
    Huang, Shile
    BIOCHEMICAL PHARMACOLOGY, 2016, 116 : 39 - 50
  • [32] EVALUATION OF CICLOPIROX OLAMINE CREAM FOR THE TREATMENT OF TINEA PEDIS - MULTICENTER, DOUBLE-BLIND COMPARATIVE STUDIES
    KLIGMAN, AM
    BOGAERT, H
    CORDERO, C
    DUNCAN, WC
    ROENIGK, HH
    SAVIN, RC
    SHALITA, AR
    LYNFIELD, Y
    STOUGHTON, RB
    WILLIS, I
    ZAIAS, N
    CLINICAL THERAPEUTICS, 1985, 7 (04) : 409 - 417
  • [33] Clotrimazole and ciclopirox olamine respectively in combination with methylprednisolone aceponate as extemporaneous formulations
    Wohlrab, J.
    Neubert, R. H. H.
    Sommer, E.
    Michael, J.
    HAUTARZT, 2017, 68 (04): : 307 - 315
  • [34] Anodic polarographic determination of ciclopirox olamine in pure and certain pharmaceutical preparations
    Ibrahim, F
    El-Enany, N
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 32 (02) : 353 - +
  • [35] LOCAL TOLERANCE OF A NEW CICLOPIROX OLAMINE VAGINAL PREPARATION IN RATS AND RABBITS
    MANZARDO, S
    PINZETTA, A
    COPPI, G
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (05) : 307 - 312
  • [36] Ciclopirox Olamine Induces Proliferation Inhibition and Protective Autophagy in Hepatocellular Carcinoma
    Wan, Xinyan
    Xiang, Junqi
    Fan, Hui
    Jiang, Ying
    Lu, Yiting
    Zhang, Chundong
    Zhang, Ying
    Chen, Quanmei
    Lei, Yunlong
    PHARMACEUTICALS, 2023, 16 (01)
  • [37] Ciclopirox olamine downregulates Cdc25A expression in tumor cells
    Shen, Tao
    Zhou, Hongyu
    Huang, Shile
    CANCER RESEARCH, 2012, 72
  • [38] CICLOPIROX OLAMINE, AND ANTIFUNGAL MODULATOR OF NEUTROPHIL FUNCTION AND INFILTRATE IN CUTANEOUS INFLAMMATION
    PRZEKOP, PA
    LEE, AA
    BAILEY, SC
    KURTZ, ES
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) : 593 - 593
  • [39] Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans
    Lee, REB
    Liu, TT
    Barker, KS
    Lee, RE
    Rogers, PD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (05) : 655 - 662
  • [40] Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent
    Hongxuan Feng
    Linghao Hu
    Hongwen Zhu
    Lingxue Tao
    Lei Wu
    Qinyuan Zhao
    Yemi Gao
    Qi Gong
    Fei Mao
    Xiaokang Li
    Hu Zhou
    Jian Li
    Haiyan Zhang
    Acta Pharmaceutica Sinica B, 2020, 10 (03) : 434 - 446